RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul B. Tchounwou to Leukemia, Promyelocytic, Acute

This is a "connection" page, showing publications Paul B. Tchounwou has written about Leukemia, Promyelocytic, Acute.
  1. Kumar S, Tchounwou PB. p53 as a unique target of action of cisplatin in acute leukaemia cells. J Cell Mol Med. 2022 09; 26(17):4727-4739.
    View in: PubMed
    Score: 0.848
  2. Kumar S, Tchounwou PB. Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells. Environ Toxicol. 2021 Sep; 36(9):1785-1792.
    View in: PubMed
    Score: 0.780
  3. Kumar S, Farah IO, Tchounwou PB. Trisenox induces cytotoxicity through phosphorylation of mitogen-activated protein kinase molecules in acute leukemia cells. J Biochem Mol Toxicol. 2018 Oct; 32(10):e22207.
    View in: PubMed
    Score: 0.643
  4. Kumar S, Tchounwou PB. Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells. Oncotarget. 2015 Dec 01; 6(38):40734-46.
    View in: PubMed
    Score: 0.533
  5. Kumar S, Yedjou CG, Tchounwou PB. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells. J Exp Clin Cancer Res. 2014 May 16; 33:42.
    View in: PubMed
    Score: 0.120
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support